Access to innovative cancer medicines in a middle-income country - the case of Mexico

BACKGROUND: Cancer has become the third cause of death in Mexico. Treatment for cancer is often complex and lengthy. New and better medicines enter the market at high prices, which may limit access. Like most Latin American countries, Mexico has an essential cancer medicines list that includes innov...

Descripción completa

Detalles Bibliográficos
Autores principales: Moye-Holz, Daniela, Soria Saucedo, Rene, van Dijk, Jitse P, Reijneveld, Sijmen A, Hogerzeil, Hans V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199792/
https://www.ncbi.nlm.nih.gov/pubmed/30386627
http://dx.doi.org/10.1186/s40545-018-0153-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199792/
https://www.ncbi.nlm.nih.gov/pubmed/30386627
http://dx.doi.org/10.1186/s40545-018-0153-y

Ejemplares similares